A detailed history of Blume Capital Management, Inc. transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Blume Capital Management, Inc. holds 400 shares of XBI stock, worth $37,836. This represents 0.01% of its overall portfolio holdings.

Number of Shares
400
Previous 500 20.0%
Holding current value
$37,836
Previous $46,000 15.22%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$90.87 - $102.43 $9,087 - $10,243
-100 Reduced 20.0%
400 $39,000
Q1 2024

May 02, 2024

SELL
$87.05 - $102.89 $43,525 - $51,445
-500 Reduced 50.0%
500 $47,000
Q4 2023

May 01, 2024

SELL
$64.12 - $90.86 $46,807 - $66,327
-730 Reduced 42.2%
1,000 $89,000
Q4 2023

Feb 06, 2024

SELL
$64.12 - $90.86 $46,807 - $66,327
-730 Reduced 42.2%
1,000 $89,000
Q3 2023

May 01, 2024

SELL
$71.88 - $85.76 $518,614 - $618,758
-7,215 Reduced 80.66%
1,730 $126,000
Q3 2023

Nov 03, 2023

SELL
$71.88 - $85.76 $518,614 - $618,758
-7,215 Reduced 80.66%
1,730 $126,000
Q2 2023

May 01, 2024

SELL
$75.38 - $90.23 $9,422 - $11,278
-125 Reduced 1.38%
8,945 $744,000
Q2 2023

Aug 10, 2023

SELL
$75.38 - $90.23 $9,422 - $11,278
-125 Reduced 1.38%
8,945 $744,000
Q1 2023

May 01, 2024

BUY
$73.13 - $91.97 $590,159 - $742,197
8,070 Added 807.0%
9,070 $691,000
Q4 2022

Feb 07, 2023

SELL
$76.72 - $85.66 $19,180 - $21,415
-250 Reduced 2.68%
9,070 $752,000
Q3 2022

Nov 15, 2022

BUY
$75.06 - $94.9 $484,137 - $612,105
6,450 Added 224.74%
9,320 $739,000
Q2 2022

Aug 11, 2022

SELL
$62.81 - $96.09 $16,330 - $24,983
-260 Reduced 8.31%
2,870 $213,000
Q1 2022

May 12, 2022

SELL
$81.07 - $115.44 $4,053 - $5,772
-50 Reduced 1.57%
3,130 $281,000
Q4 2021

Feb 07, 2022

BUY
$108.77 - $134.15 $59,823 - $73,782
550 Added 20.91%
3,180 $356,000
Q1 2021

May 10, 2021

SELL
$129.36 - $173.99 $9,702 - $13,049
-75 Reduced 2.77%
2,630 $357,000
Q4 2020

Feb 09, 2021

SELL
$110.36 - $151.14 $33,108 - $45,341
-300 Reduced 9.98%
2,705 $381,000
Q3 2020

Nov 12, 2020

BUY
$103.87 - $120.36 $2,596 - $3,009
25 Added 0.84%
3,005 $335,000
Q2 2020

Aug 06, 2020

SELL
$73.26 - $114.17 $1,831 - $2,854
-25 Reduced 0.83%
2,980 $334,000
Q1 2020

May 07, 2020

BUY
$65.95 - $98.35 $6,595 - $9,835
100 Added 3.44%
3,005 $232,000
Q4 2019

Feb 05, 2020

BUY
$74.65 - $98.46 $44,790 - $59,075
600 Added 26.03%
2,905 $276,000
Q3 2019

Nov 12, 2019

SELL
$76.25 - $83.86 $1,906 - $2,096
-25 Reduced 1.07%
2,305 $175,000
Q1 2019

May 06, 2019

BUY
N/A
300 Added 14.78%
2,330 $211,000
Q4 2018

Feb 05, 2019

BUY
N/A
50 Added 2.53%
2,030 $146,000
Q2 2018

Aug 02, 2018

BUY
N/A
75 Added 3.94%
1,980 $188,000
Q1 2018

May 04, 2018

BUY
N/A
1,800 Added 1714.29%
1,905 $167,000
Q3 2017

Nov 13, 2017

BUY
N/A
105
105 $9,000

Others Institutions Holding XBI

About SPDR SER TR SPDR S&P BIOTECH E


  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Blume Capital Management, Inc. Portfolio

Follow Blume Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blume Capital Management, Inc. with notifications on news.